Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ · Healthcare
Vertex Pharmaceuticals Incorporated Gross Profit 2008–2025
Vertex Pharmaceuticals Incorporated annual/quarterly gross profit history and growth rate from 2010 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Vertex Pharmaceuticals Incorporated gross profit for the quarter ending March 31, 2026 was 2.6 B, a 7.76% increase year-over-year.
- Vertex Pharmaceuticals Incorporated gross profit for the twelve months ending March 31, 2026 was 10.2 B, a 11.50% increase year-over-year.
- Vertex Pharmaceuticals Incorporated annual gross profit for 2025 was 10.3 B, a 9.07% increase from 2024.
- Vertex Pharmaceuticals Incorporated annual gross profit for 2024 was 9.5 B, a 10.25% increase from 2023.
- Vertex Pharmaceuticals Incorporated annual gross profit for 2023 was 8.6 B, a 9.64% increase from 2022.
- Vertex Pharmaceuticals Incorporated annual gross profit for 2022 was 7.9 B.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Vertex Pharmaceuticals Inc. Gross Profit — FAQ
Vertex Pharmaceuticals Inc. (VRTX) gross profit over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
What is Vertex Pharmaceuticals Inc.'s gross profit?
Vertex Pharmaceuticals Inc. (VRTX) reported gross profit of $10.35B for fiscal 2025.
Where can I see VRTX's gross profit history?
The chart and table above show Vertex Pharmaceuticals Inc.'s gross profit by year and by quarter, including the growth rate.